Practical insights on due diligence in the life sciences and healthcare sector covering pharmaceutical, biotechnology, diagnostics and medical devices area. Get acquainted with state-of-the-art concepts and practices to make optimal decisions.
How to Conduct Advanced Competitive Benchmarking in the Biopharma Industry In the fiercely competitive landscape of the biopharmaceutical industry, staying ahead requires not just innovation but also a keen understanding…
Pharmaceutical R&D Trends 2025: Key Insights and Strategic Shifts The pharmaceutical industry is at a critical inflection point in 2025, with research and development (R&D) continuing to grow despite global…
Enhancing Biopharma Licensing and Partnering Through Comparative Evaluation The biopharmaceutical industry landscape is constantly evolving, and in-licensing and partnering deals are vital corporate strategies for driving innovation, devising new products,…
How to Determine an Accurate Addressable Market Size in Life Sciences Commercial Due Diligence Market size is one of the critical elements in the life sciences commercial due diligence, new…
How to Conduct Robust Commercial Due Diligence by Looking Beyond Generics in Pharma Businesses Investors need to look beyond generics in the pharmaceutical commercial due diligence (CDD) for investment in…
How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…
Win-win Investment Opportunities in Digital Health and IoT for Life Sciences Investors and Pharma Industry Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical companies. The…
Key Success Factors for Effective Pharmaceutical Due Diligence and Risk Mitigation Due diligence is defined as the process by which buyers conduct the evaluation of investment opportunities. Several factors are…